[NRIX] YoY Quarter Result on 31-May-2023 [#Q2]

Stock
[NRIX] Nurix Therapeutics, Inc.
Announcement Date
13-Jul-2023
Financial Year
2023
Quarter
31-May-2023 [#Q2]
Profit Trend
QoQ- 38.33%
YoY- 51.67%
Quarter Report
NRIX's Result
NRIX's Financial Summary
View:
Show?
Quarter Result
31/05/24 31/05/23 31/05/22 31/05/21 31/05/20 31/05/19 CAGR
Revenue 12,092 30,676 11,432 7,091 4,182 9,439 5.07%
PBT -44,456 -24,277 -45,401 -26,243 -13,007 -3,058 70.70%
Tax 90 -2,488 -314 139 -20,587 10 55.10%
NP -44,546 -21,789 -45,087 -26,382 7,580 -3,068 70.66%
Tax Rate - - - - - - -
Total Cost 56,638 52,465 56,519 33,473 -3,398 12,507 35.22%
Ratio Analysis
31/05/24 31/05/23 31/05/22 31/05/21 31/05/20 31/05/19 CAGR
NP Margin -368.39 -71.03 -394.39 -372.05 181.25 -32.50 62.42%
Per Share
31/05/24 31/05/23 31/05/22 31/05/21 31/05/20 31/05/19 CAGR
EPS -0.71 -0.40 -1.00 -0.60 0.22 -0.94 -5.45%
EPS Diluted -0.71 -0.40 -1.00 -0.60 0.22 -0.94 -5.45%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.